Back to top

Press Releases

Zacks Equity Research

The Zacks Analyst Blog Highlights: Biogen, Honda, Intel, CSX and General Growth Properties

BIIB HMC INTC CSX GGP

Trades from $3

For Immediate Release

Chicago, IL – November 17, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Biogen (NASDAQ: (BIIB - Free Report) -Free Report ), Honda (NYSE: (HMC - Free Report) -Free Report ), Intel (NASDAQ: (INTC - Free Report) -Free Report ), CSX Corp. (NASDAQ:(CSX - Free Report) -Free Report) andGeneral Growth Properties (NYSE:(GGP - Free Report) -Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday’s Analyst Blog:

Top Research Reports for Today: INTC, HMC, BIIB

Today's Research Daily features new research reports on 16 major stocks, including Biogen (NASDAQ: (BIIB - Free Report) -Free Report ), Honda (NYSE: (HMC - Free Report) -Free Report ) and Intel (NASDAQ: (INTC - Free Report) -Free Report ).

Biogen shares have outperformed the broader pharma space, with the stock enthusiastically participating in the post-election rally on hopes of a friendlier regulatory regime under the incoming administration. This tailwind notwithstanding, the analyst likes its strong position in the multiple sclerosis market primarily due to a wide range of products. Cost cutting efforts and MS franchise sales should continue to drive growth. Moreover, the upcoming spin-off of the hemophilia business will allow Biogen to focus on the neurology segment, its key area of expertise. However, the emergence of new PML cases for Tecfidera would weigh heavily on the stock as would pipeline setbacks. Interferon products are also under pressure with patients shifting to oral therapies. (You can read the full research report on Biogen here >> )

Honda shares continued to lag its auto peers, with frequent recalls related to the Takata airbags and the weak Q3 earnings report weighing on the stock. Weak guidance for 2017 and sales problems in the home market are some of the other issues in the Honda story. In the fresh research report issued today, the Zacks analyst discusses the pros & cons of investing in Honda shares. The analyst points out that offsetting the current headwinds, the company has a broad product line-up and expanding operations across Asia. The analyst also likes the company's focus on product and infrastructure development. (You can read the full research report on Honda here>>)

Intel shares have lagged the semiconductor space this year, with the company's weak Q3 results adding to the underperformance. The company beat on the top - and bottom-line in Q3, but guidance came as a disappointment, particularly with respect to margins as well as capex. The market's reaction notwithstanding, the Zacks analyst likes the momentum in the data center group, where macro factors are impacting the enterprise side even as cloud prospects remain strong. Intel’s investments in IoT, security and memory could also pay off this year. (You can read the full research report on Intel here>>)

Other noteworthy reports we are featuring today include CSX Corp. (NASDAQ:(CSX - Free Report) -Free Report) and General Growth Properties (NYSE:(GGP - Free Report) -Free Report).

Free Access: All Zacks Research Reports
Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks. Valued at $25 each, they are yours to consult over the next 30 days absolutely free. They feature sensitive Zacks Rank information on each stock that you won't find anywhere else. See the reports free >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on BIIB - FREE

Get the full Report on HMC - FREE

Get the full Report on INTC - FREE

Get the full Report on CSX - FREE

Get the full Report on GGP - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.